Hypoxia-regulated glial cell-specific gene therapy to treat retinal neovascularization
Diabetic retinopathy is an ischemic retinal neovascular disease causing vision loss among adults. The studies presented involve the design and testing of a gene therapy vector to inhibit retinal revascularization, similar to that found in diabetic retinopathy. Gene therapy has proven to be an effect...
Other Authors: | Biswal, Manas Ranjan. |
---|---|
Format: | Others |
Language: | English |
Published: |
Florida Atlantic University
|
Subjects: | |
Online Access: | http://purl.flvc.org/FAU/3359290 |
Similar Items
- Hypoxia-regulated gene therapy for the treatment of subretinal neovascularization in age-related macular degeneration
-
Non-apoptotic Caspase-8 Signaling Mediates Retinal Angiogenesis
by: Johnson, Kendra Vincia
Published: (2021) -
Targeting Neuroinflammation in Neovascular Retinal Diseases
by: Tianxi Wang, et al.
Published: (2020-03-01) -
Diverse roles of macrophages in intraocular neovascular diseases: a review
by: Ye-Di Zhou, et al.
Published: (2017-12-01) -
Peripheral Retinal Neovascularization with Vitreous Hemorrhage in HIV Retinopathy
by: Kim Jiramongkolchai, et al.
Published: (2017-06-01)